Chapter 3. Neurophysiology: The Generation, Transmission, and Integration of Neural Signals

Follow us on Facebook and Twitter, or subscribe to our mailing list, to receive news updates. Learn more.


Links 41 - 60 of 640

by Bethany Brookshire When neurons throughout the brain and body send messages, they release chemical signals. These chemicals, neurotransmitters, pass into the spaces between neurons, or synapses, binding to receptors to send a signal along. When they are not in use, neurotransmitters are stored within the cell in tiny bubbles called vesicles. During signaling, these vesicles head to the membrane of the neuron, where they dump neurotransmitter into the synapse. And after delivering their cargo, most vesicles disappear. But more vesicles keep forming, filling with neurotransmitters so neurons can keep sending signals. What goes up must come down. When vesicles go out, they must come back. But how fast to the vesicles re-appear? Must faster, it turns out, than we first thought. Neurotransmission happens fast. An electrical signal comes down a neuron in your brain and triggers vesicles to move to the cell membrane. When the vesicles merge into the membrane and release their chemical cargo, the neurotransmitters float across the open synapse to the next neuron. This happens every time the neuron “fires.” This needs to happen very quickly, as neurons often fire at 100 hertz, or 100 times per second. Some neurons perform a “kiss-and-run,” opening up a temporary pore in the membrane, releasing a little bit of neurotransmitter and darting away again. Other vesicles need to merge with the synapse entirely. With the assistance of docking proteins, these vesicles fuse with the membrane of the neuron to release the neurotransmitters, a process called exocytosis. © Society for Science & the Public 2000 - 2013.

Keyword: Miscellaneous
Link ID: 19021 - Posted: 12.11.2013

By Helen Briggs BBC News An anti-tuberculosis vaccine could prevent multiple sclerosis, early research suggests. A small-scale study by researchers at the Sapienza University of Rome has raised hopes that the disease can be warded off when early symptoms appear. More research is needed before the BCG vaccine can be trialled on MS patients. The MS Society said the chance to take a safe and effective preventative treatment after a first MS-like attack would be a huge step forward. MS is a disease affecting nerves in the brain and spinal cord, causing problems with muscle movement, balance and vision. Early signs include numbness, vision difficulties or problems with balance. About half of people with a first episode of symptoms go on to develop MS within two years, while 10% have no more problems. In the study, published in the journal Neurology, Italian researchers gave 33 people who had early signs of MS an injection of BCG vaccine. The other 40 individuals in the study were given a placebo. After five years, 30% of those who received the placebo had not developed MS, compared with 58% of those vaccinated. "These results are promising, but much more research needs to be done to learn more about the safety and long-term effects of this live vaccine," said study leader Dr Giovanni Ristori. "Doctors should not start using this vaccine to treat MS or clinically isolated syndrome." BBC © 2013

Keyword: Multiple Sclerosis
Link ID: 19003 - Posted: 12.05.2013

Peter Hildebrand Neuroscience is a rapidly growing field, but one that is usually thought to be too complex and expensive for average Americans to participate in directly. Now, an explosion of cheap scientific devices and online tutorials are on the verge of changing that. This change could have exciting implications for our future understanding of the brain. From 1995 to 2005, the amount of money spent on neuroscience research doubled. A lot of that research used medical devices, like MRI and CT Scan machines, and drugs that everyday citizens don’t have access to. Even in colleges, experience with powerful research equipment is reserved for upperclassmen and graduate students. The lowlier castes can work with models or dissect animal brains, but as scientist and engineer Greg Gage points out in this TED video, the brain isn’t like the heart or the lungs. You can’t tell how it works just by looking at it. Gage is calling for “neuro-revolution,” in which scientists and inventors come together to put the tools for learning neuroscience into the hands of the public. He may be onto something too, because those tools are looking more accessible than ever before. One of the most well publicized examples of this punk rock revolution has been Gage’s own “SpikerBox,” which he co-developed with Tim Marzullo. Roughly the size of your fist, the SpikerBox is a small collection of electronic components bolted between two squares of orange plastic. Coming out of one end are two pins that you can use to record the electrical activity of nerve cells in, say, a recently severed cockroach leg. There’s also a port that allows you to attach the box to a smartphone or tablet, and watch the spikes of activity as the neurons are stimulated. © 2013 Salon Media Group, Inc.

Keyword: Brain imaging
Link ID: 18976 - Posted: 11.26.2013

Jessica Wright A tiny fiber-optic probe inserted into the reward center of the mouse brain monitors how the mouse feels about meeting a peer — or a golf ball. The unpublished technique was presented last week at the at the 2013 Society for Neuroscience annual meeting in San Diego. Mice feel the most satisfaction when sniffing another mouse’s rear and when walking away from a golf ball, the study found. The new technique is one of only a few ways to read the electrical activity of neurons in freely moving mice and is the most noninvasive, making it ideal for monitoring social interactions. The method takes advantage of a fluorescent molecule that lights up only in the presence of calcium, which rushes into the cell when neurons fire. The researchers used mice engineered to express this molecule only in neurons that make dopamine — the chemical messenger that mediates a sense of reward — in the ventral tegmental area (VTA). The researchers placed the cable in the VTA, the source of most of the brain’s dopamine neurons. The fiber-optic cable is 400 micrometers in diameter, and could probably be half that size, says Lisa Gunaydin, who developed the method as a graduate student in Karl Deisseroth’s lab at Stanford University in California. When neurons expressing the fluorescent molecule fire, the cable reads these as a series of spikes. In the study, the researchers gave thirsty mice sweet water and, as expected, their dopamine activity in the VTA spiked each time they drank. When the mice interact with a new mouse, or a golf ball, the dopamine neurons fire more on the first encounter but dull with repeated visits, suggesting that the mice are most excited by novelty. © Copyright 2013 Simons Foundation

Keyword: Drug Abuse
Link ID: 18949 - Posted: 11.21.2013

Helen Shen Long used to treat movement disorders, deep-brain stimulation (DBS) is rapidly emerging as an experimental therapy for neuropsychiatric conditions including depression, Tourette’s syndrome, obsessive–compulsive disorder and even Alzheimer’s disease. But despite some encouraging results in patients, it remains largely unknown how the electrical pulses delivered by implants deep within the brain affect neural circuits and change behaviour. Now there is a prototype DBS device that could provide some answers, researchers reported on 10 November at the Society for Neuroscience’s annual meeting in San Diego, California. Called Harmoni, the device is the first DBS implant to monitor electrical and chemical responses in the brain while delivering electrical stimulation. “That’s new data that we haven’t really had access to in humans before,” says Cameron McIntyre, a biomedical engineer at Case Western Reserve University in Cleveland, Ohio, who is not involved in the work. Researchers hope that the device will identify the electrical and chemical signals in the brain that correlate in real time with the presence and severity of symptoms, including the tremors experienced by people with Parkinson’s disease. This information could help to uncover where and how DBS exerts its therapeutic effects on the brain, and why it sometimes fails, says Kendall Lee, a neurosurgeon at the Mayo Clinic in Rochester, Minnesota, who is leading the project. The results come at a time of great excitement in the DBS field. Last month, the US government's Defense Advanced Research Projects Agency (DARPA) announced a 5-year, US$70-million initiative to support development of the next generation of therapeutic brain-stimulating technologies. © 2013 Nature Publishing Group,

Keyword: Parkinsons
Link ID: 18922 - Posted: 11.13.2013

M. Mitchell Waldrop Kwabena Boahen got his first computer in 1982, when he was a teenager living in Accra. “It was a really cool device,” he recalls. He just had to connect up a cassette player for storage and a television set for a monitor, and he could start writing programs. But Boahen wasn't so impressed when he found out how the guts of his computer worked. “I learned how the central processing unit is constantly shuffling data back and forth. And I thought to myself, 'Man! It really has to work like crazy!'” He instinctively felt that computers needed a little more 'Africa' in their design, “something more distributed, more fluid and less rigid”. Today, as a bioengineer at Stanford University in California, Boahen is among a small band of researchers trying to create this kind of computing by reverse-engineering the brain. The brain is remarkably energy efficient and can carry out computations that challenge the world's largest supercomputers, even though it relies on decidedly imperfect components: neurons that are a slow, variable, organic mess. Comprehending language, conducting abstract reasoning, controlling movement — the brain does all this and more in a package that is smaller than a shoebox, consumes less power than a household light bulb, and contains nothing remotely like a central processor. To achieve similar feats in silicon, researchers are building systems of non-digital chips that function as much as possible like networks of real neurons. Just a few years ago, Boahen completed a device called Neurogrid that emulates a million neurons — about as many as there are in a honeybee's brain. And now, after a quarter-century of development, applications for 'neuromorphic technology' are finally in sight. © 2013 Nature Publishing Group

Keyword: Robotics; Learning & Memory
Link ID: 18891 - Posted: 11.08.2013

By Bradley E. Alger, Ph.D. Cannabis, derived from a plant and one of the oldest known drugs, has remained a source of controversy throughout its history. From debates on its medicinal value and legalization to concerns about dependency and schizophrenia, cannabis (marijuana, pot, hashish, bhang, etc.) is a hot button for politicians and pundits alike. Fundamental to understanding these discussions is how cannabis affects the mind and body, as well as the body’s cells and systems. How can something that stimulates appetite also be great for relieving pain, nausea, seizures, and anxiety? Whether its leaves and buds are smoked, baked into pastries, processed into pills, or steeped as tea and sipped, cannabis affects us in ways that are sometimes hard to define. Not only are its many facets an intrinsically fascinating topic, but because they touch on so many parts of the brain and the body, their medical, ethical, and legal ramifications are vast. The intercellular signaling molecules, their receptors, and synthetic and degradative enzymes from which cannabis gets its powers had been in place for millions of years by the time humans began burning the plants and inhaling the smoke. Despite records going back 4,700 years that document medicinal uses of cannabis, no one knew how it worked until 1964. That was when Yechiel Gaoni and Raphael Mechoulam1 reported that the main active component of cannabis is tetrahydrocannabinol (THC). THC, referred to as a “cannabinoid” (like the dozens of other unique constituents of cannabis), acts on the brain by muscling in on the intrinsic neuronal signaling system, mimicking a key natural player, and basically hijacking it for reasons best known to the plants. Since the time when exogenous cannabinoids revealed their existence, the entire natural complex came to be called the “endogenous cannabinoid system,” or “endocannabinoid system” (ECS). Copyright 2013 The Dana Foundation

Keyword: Drug Abuse
Link ID: 18874 - Posted: 11.06.2013

by Anil Ananthaswamy THE first clinical trial aimed at boosting social skills in people with autism using magnetic brain stimulation has been completed – and the results are encouraging. "As a first clinical trial, this is an excellent start," says Lindsay Oberman of the Beth Israel Deaconess Medical Centre in Boston, who was not part of the study. People diagnosed with autism spectrum disorder often find social interactions difficult. Previous studies have shown that a region of the brain called the dorsomedial prefrontal cortex (dmPFC) is underactive in people with autism. "It's also the part of the brain linked with understanding others' thoughts, beliefs and intentions," says Peter Enticott of Monash University in Melbourne, Australia. Enticott and his colleagues wondered whether boosting the activity of the dmPFC using repetitive transcranial magnetic stimulation (rTMS), which involves delivering brief but strong magnetic pulses through the scalp, could help individuals with autism deal with social situations. So the team carried out a randomised, double-blind clinical trial – the first of its kind – involving 28 adults diagnosed with either high-functioning autism or Asperger's syndrome. Some participants received 15 minutes of rTMS for 10 days, while others had none, but experienced all other aspects, such as having coils placed on their heads and being subjected to the same sounds and vibrations. © Copyright Reed Business Information Ltd.

Keyword: Autism
Link ID: 18863 - Posted: 11.02.2013

/ by Charles Choi, LiveScience Using lasers, scientists can now surgically blast holes thinner than a human hair in the heads of live fruit flies, allowing researchers to see how the flies' brains work. Microscopically peering into living animals can help scientists learn more about key details of these animals' biology. For instance, tiny glass windows surgically implanted into the sides of living mice can help researchers study how cancers develop in real time and evaluate the effectiveness of potential medicines. Surgically preparing small live animals for such "intravital microscopy" is often time-consuming and requires considerable skill and dexterity. Now, Supriyo Sinha, a systems engineer at Stanford University in California, and his colleagues have developed a way to prepare live animals for such microscopy that is both fast -- taking less than a second -- and largely automated. To conduct this procedure, scientists first cooled fruit flies to anesthetize them. Then, the researchers carefully picked up the insects with tweezers and glued them to the tops of glass fibers in order to immobilize the flies' bodies and heads. Then, using a high-energy pulsed ultraviolet laser, the researchers blasted holes measuring 12 to 350 microns wide in the flies' heads. (In comparison, the average human hair is about 100 microns wide.) They then applied a saline solution to exposed tissue to help keep the fly brains healthy. © 2013 Discovery Communications, LLC.

Keyword: Miscellaneous
Link ID: 18861 - Posted: 11.02.2013

By KATE MURPHY Whether it’s hitting a golf ball, playing the piano or speaking a foreign language, becoming really good at something requires practice. Repetition creates neural pathways in the brain, so the behavior eventually becomes more automatic and outside distractions have less impact. It’s called being in the zone. But what if you could establish the neural pathways that lead to virtuosity more quickly? That is the promise of transcranial direct current stimulation, or tDCS — the passage of very low-level electrical current through targeted areas of the brain. Several studies conducted in medical and military settings indicate tDCS may bring improvements in cognitive function, motor skills and mood. Some experts suggest that tDCS might be useful in the rehabilitation of patients suffering from neurological and psychological disorders, perhaps even in reducing the time and expense of training healthy people to master a skill. But the research is preliminary, and now there is concern about a growing do-it-yourself community, many of them video gamers, who are making tDCS devices with nine-volt batteries to essentially jump-start their brains. “If tDCS is powerful enough to do good, you have to wonder if, done incorrectly, it could cause harm,” said Dr. H. Branch Coslett, chief of the cognitive neurology section at the University of Pennsylvania School of Medicine and a co-author of studies showing that tDCS improves recall of proper names, fosters creativity and improves reading efficiency. Even the tDCS units used in research are often little more than a nine-volt battery with two electrodes and a controller for setting the current and the duration of the session. Several YouTube videos show how to make a rough facsimile. © 2013 The New York Times Company

Keyword: Miscellaneous
Link ID: 18848 - Posted: 10.29.2013

by Tina Hesman Saey BOSTON — A variant in a gene involved in breaking down chemicals in smoke triples a smoker’s risk of multiple sclerosis, a study shows. Smoking increases by 30 to 50 percent a person’s risk of multiple sclerosis, a disease in which the immune system attacks a waxy coating around nerve cells. Scientists don’t know exactly how smoking contributes to the disease. Farren Briggs of the University of California, Berkeley and his colleagues searched DNA of thousands of people in Northern California, Norway and Sweden for genetic variants associated with both smoking and multiple sclerosis. The team found hundreds of variants in three genes involved in breaking down chemicals found in smoke, Briggs said October 24 at the annual meeting of the American Society of Human Genetics. In particular, people who smoke and who have two copies of a variant in the NAT1 gene have a risk of getting MS that is three times higher than that of smokers without the variant. For nonsmokers, the variant doesn’t increase MS risk. Citations F.B.S. Briggs et al. NAT1 in an important genetic effect modifier of tobacco smoke exposure in multiple sclerosis susceptibility in 5,453 individuals. American Society of Human Genetics annual meeting, Boston, October 24, 2013. Further Reading N. Seppa. Old drug may have new trick. Science News. Vol. 184, November 2, 2013, p. 16. N. Seppa. Black women may have highest multiple sclerosis rates. Science News. Vol. 183, June 15, 2013, p. 15. © Society for Science & the Public 2000 - 2013

Keyword: Multiple Sclerosis; Genes & Behavior
Link ID: 18832 - Posted: 10.26.2013

Special Note to Teachers: The content of the following lesson plans compares the “normal” brain to a “zombie” brain. Zombies are not real but there are plenty of diseases that effect real people and students may have people in their lives who have suffered because of them. The following lessons about neuroscience have been inspired by the book, “The Zombie Autopsies”, written by Steven C. Schlozman, M.D., and are intended to compliment it. “The Zombie Autopsies” was inspired by George Romero’s 1968 cult-classic horror film “Night of the Living Dead”. These original lessons build upon each other and have an accompanying plot line where the world is fighting a zombie apocalypse and the best and the brightest young people are being trained as medical students – with a specialty in neuroscience – with the hopes that they will be able to provide a cure to this terrible epidemic and save humanity. For a richer experience have the students read the book in class and as homework (see suggested reading schedule) along with the class activities. Although the materials are organized as a unit, lessons can be used as stand-alone or can be shaped to fit the needs of you and your students regarding time and content. For example, Lesson 3 is perfect for the day of Halloween. © 2013 MacNeil-Lehrer Productions

Keyword: Learning & Memory
Link ID: 18824 - Posted: 10.23.2013

A narrowing of the veins from the brain is unlikely as a cause multiple sclerosis, say researchers from B.C. and Saskatchewan who found the narrowing is a common and normal finding in most people. Italian Paolo Zamboni made headlines in Canada four years ago for his belief that clearing blocked or narrowed neck veins could relieve MS symptoms. Since then probably more than 3,000 Canadians have gone out of country for dilation treatment, said Dr. Anthony Traboulsee of the University of British Columbia. In Tuesday's online issue of the The Lancet, Traboulsee and his co-authors published their findings on the prevalence of narrowing, known as chronic cerebrospinal venous insufficiency or CCSVI, in people with MS, their siblings and unrelated healthy controls. Using catheter venography to directly visualize veins, the researchers found three people tested positive for CCSVI: One of 65 (2 per cent) of those with MS. One of 46 (2 per cent) of siblings. One of 32 (3 per cent) on unrelated controls. "This was a big surprise to all of us," Traboulsee told reporters. "We were really expecting to find many more people with this feature." When the researchers used ultrasound to look for CCSVI, they found narrowing in more than 50 per cent of all three groups. The hypothesis that vein narrowing has a role in the cause of MS is unlikely since its prevalence was similar in all three groups, the study's authors concluded. © CBC 2013

Keyword: Multiple Sclerosis
Link ID: 18765 - Posted: 10.09.2013

At the TEDx conference in Detroit last week, RoboRoach #12 scuttled across the exhibition floor, pursued not by an exterminator but by a gaggle of fascinated onlookers. Wearing a tiny backpack of microelectronics on its shell, the cockroach—a member of the Blaptica dubia species—zigzagged along the corridor in a twitchy fashion, its direction controlled by the brush of a finger against an iPhone touch screen (as seen in video above). RoboRoach #12 and its brethren are billed as a do-it-yourself neuroscience experiment that allows students to create their own “cyborg” insects. The roach was the main feature of the TEDx talk by Greg Gage and Tim Marzullo, co-founders of an educational company called Backyard Brains. After a summer Kickstarter campaign raised enough money to let them hone their insect creation, the pair used the Detroit presentation to show it off and announce that starting in November, the company will, for $99, begin shipping live cockroaches across the nation, accompanied by a microelectronic hardware and surgical kits geared toward students as young as 10 years old. That news, however, hasn’t been greeted warmly by everyone. Gage and Marzullo, both trained as neuroscientists and engineers, say that the purpose of the project is to spur a “neuro-revolution” by inspiring more kids to join the fields when they grow up, but some critics say the project is sending the wrong message. "They encourage amateurs to operate invasively on living organisms" and "encourage thinking of complex living organisms as mere machines or tools," says Michael Allen Fox, a professor of philosophy at Queen's University in Kingston, Canada. © 2013 American Association for the Advancement of Science

Keyword: Animal Rights
Link ID: 18755 - Posted: 10.08.2013

By Julianne Chiaet It has taken a century so far for scientists to not figure out the cause of multiple sclerosis (MS). The inflammatory disease, which affects more than 2.1 million people worldwide, has been blamed on toxins, viruses and even food. Most recently, scientists have placed their bets on two major ideas: The first (and far more popular) hypothesis suggests MS begins in white matter, which influences how parts of the brain work together. White matter consists of bundles of axons covered in myelin, a white insulating fatty layer. In people with MS myelin degrades and nerve fibers are left exposed, causing problems in motor coordination and loss of senses. The second hypothesis suggests that MS begins in the gray matter, which affects thinking and learning. The white matter hypothesis overshadows its alternative in part because white matter’s impact is easier to observe. When using a microscope to look at brain tissue, scientists are struck by the degradation in the myelin in samples from patients with MS. And when analyzing MS in the clinic, the overt symptoms experienced by a person with the disease can be attributed to the myelin. Symptoms associated with dysfunctions in gray matter are less obvious, such as the loss of an IQ point. Now, new evidence lends support to the less-favored gray matter hypothesis. Scientists at Rutgers University in Newark tried a new approach to look into the gray matter of MS patients. They analyzed proteins in cerebrospinal fluid (CSF), which can be thought of as the central nervous system’s “blood.” By comparing the quantity of specific CSF proteins in patients who were newly diagnosed or had the relapsing remitting variety of MS with that of healthy patients, the researchers found an uneven distribution of 20 proteins among the three groups. © 2013 Scientific American

Keyword: Multiple Sclerosis; Neuroimmunology
Link ID: 18684 - Posted: 09.21.2013

by Andy Coghlan Parts of the brain may still be alive after a person's brain activity is said to have flatlined. When someone is in a deep coma, their brain activity can go silent. An electroencephalogram measuring this activity may eventually show a flatline, usually taken as a sign of brain death. However, while monitoring a patient who had been placed in a deep coma to prevent seizures following a cardiac arrest, Bogdan Florea, a physician at the Regina Maria Medical Centre in Cluj-Napoca, Romania, noticed a strange thing – some tiny intermittent bursts of activity were interrupting an otherwise flatline signal, each lasting a few seconds. He asked Florin Amzica of the University of Montreal in Canada and his colleagues to investigate what might be happening. To imitate what happened in the patient, Amzica's team put cats into a deep coma using a high dose of anaesthesia. While EEG recordings taken from the surface of the brain – the cortex – showed a flatline, recordings from deep-brain electrodes revealed tiny bursts of activity originating in the hippocampus, responsible for memory and learning, which spread within minutes to the cortex. "These ripples build up a synchrony that rises in a crescendo to reach a threshold where they can spread beyond the hippocampus and trigger activity in the cortex," says Amzica. © Copyright Reed Business Information Ltd.

Keyword: Consciousness
Link ID: 18683 - Posted: 09.21.2013

By Associated Press, Former Grateful Dead drummer Mickey Hart has a new piece of equipment accompanying him on his latest tour: a cap fitted with electrodes that capture his brain activity and direct the movements of a light show while he’s jamming on stage. The sensor-studded headgear is an outgrowth of collaboration between Hart, 70, and Adam Gazzaley, a University of California at San Francisco neuroscientist who studies cognitive decline. The subject has been an interest of the musician’s since the late 1980s, as he watched his grandmother deal with Alzheimer’s disease. When he played the drums for her, he says, she became more responsive. Since then, Hart has invested time and money exploring the therapeutic potential of rhythm. Thirteen years ago, he founded Rhythm for Life, a nonprofit promoting drum circles for the elderly. Hart first publicly wore his electroencephalogram cap last year at an AARP convention where he and Gazzaley discussed their joint pursuit of research on the link between brain waves and memory. He wore it again while making his new album, “Superorganism,” translating the rhythms of his brain waves into music. Hart’s bandmates, with input from other researchers in Gazzaley’s lab, paired different waves with specific musical sequences that were then inserted into songs. © 1996-2013 The Washington Post

Keyword: Brain imaging; Robotics
Link ID: 18656 - Posted: 09.17.2013

Two pioneers in the study of neural signaling and three researchers responsible for modern cochlear implants are winners of The Albert and Mary Lasker Foundation’s annual prize, announced today. The prestigious award honoring contributions in the medical sciences is often seen as a hint at future Nobel contenders. The prizes for basic and clinical research each carry a $250,000 honorarium. Richard Scheller of the biotech company Genentech and Thomas Südhof of Stanford University in Palo Alto, California, got their basic research Laskers for discovering the mechanisms behind rapid the release of neurotransmitters—the brain’s chemical messengers—into the space between neurons. This process underlies all communication among brain cells, and yet it was “a black box” before Scheller and Südhof’s work, says their colleague Robert Malenka, a synaptic physiologist at Stanford. The two worked independently in the late 1980s to identify individual proteins that mediate the process, and their development of genetically altered mice lacking these proteins was “an ambitious and high-risk approach,” Malenka says. Although “they weren’t setting out to understand any sort of disease,” their discoveries have helped unravel the genetic basis for neurological disorders such as Parkinson’s disease. This year’s clinical research prizes went to Graeme Clark, Ingeborg Hochmair, and Blake Wilson for their work to restore hearing to the deaf. In the 1970s, Hochmair and Clark of the cochlear implant company MED-EL in Innsbruck, Austria, and the University of Melbourne, respectively, were the first to insert multiple electrodes into the human cochlea to stimulate nerves that respond to different frequencies of sound. © 2012 American Association for the Advancement of Science

Keyword: Hearing; Robotics
Link ID: 18625 - Posted: 09.10.2013

By Athena Andreadis Recently, two studies surfaced almost simultaneously that led to exclamations of “Vulcan mind meld!”, “Zombie armies!” and “Brains in jars!” One is the announcement by Rajesh Rao and Andrea Stocco of Washington U. that they “achieved the first human-to-human brain interface”. The other is the Nature paper by Madeline Lancaster et al about stem-cell-derived “organoids” that mimic early developmental aspects of the human cortex. My condensed evaluation: the latter is far more interesting and promising than the former, which doesn’t quite do what people (want to) think it’s doing. The purported result of brain interfacing hit many hot buttons that have been staples of science fiction and Stephen King novels: primarily telepathy, with its fictional potential for non-consensual control. Essentially, the sender’s EEG (electroencephalogram) output was linked to the receiver’s TMS (transcranial magnetic stimulation) input. What the experiment actually did is not send a thought but induce a muscle twitch; nothing novel, given the known properties of the two technologies. The conditions were severely constrained to produce the desired result and I suspect the outcome was independent of the stimulus details: the EEG simply recorded that a signal had been produced and the TMS apparatus was positioned so that a signal would elicit a movement of the right hand. Since both sender and receiver were poised over a keyboard operating a video game, the twitch was sufficient to press the space bar, programmed by the game to fire a cannon. © 2013 Scientific American

Keyword: Robotics
Link ID: 18623 - Posted: 09.10.2013

According to new research on epilepsy, zebrafish have certainly earned their stripes. Results of a study in Nature Communications suggest that zebrafish carrying a specific mutation may help researchers discover treatments for Dravet syndrome (DS), a severe form of pediatric epilepsy that results in drug-resistant seizures and developmental delays. Scott C. Baraban, Ph.D., and his colleagues at the University of California, San Francisco (UCSF), carefully assessed whether the mutated zebrafish could serve as a model for DS, and then developed a new screening method to quickly identify potential treatments for DS using these fish. This study was supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health and builds on pioneering epilepsy zebrafish models first described by the Baraban laboratory in 2005. Dravet syndrome is commonly caused by a mutation in the Scn1a gene, which encodes for Nav1.1, a specific sodium ion channel found in the brain. Sodium ion channels are critical for communication between brain cells and proper brain functioning. The researchers found that the zebrafish that were engineered to have the Scn1a mutation that causes DS in humans exhibited some of the same characteristics, such as spontaneous seizures, commonly seen in children with DS. Unprovoked seizure activity in the mutant fish resulted in hyperactivity and whole-body convulsions associated with very fast swimming. These types of behaviors are not seen in normal healthy zebrafish.

Keyword: Epilepsy
Link ID: 18603 - Posted: 09.04.2013